Clinical Chemistry · 1997 · 159 citations · 39 references
MedicineGeneticsHematologyHemostasisHuman GeneticsMedical GeneticsCoagulation AbnormalitiesCoagulation DisordersCoagulation Factor DeficienciesHemostatic DisordersThrombosisThrombotic DisordersActivated Protein C ResistanceFactor V Leiden ThrombophiliaFactor V MutationGenetic ThrombophiliaInherited Coagulation Factor DeficienciesMutationProthrombin G20210a MutationThrombotic Risk Assessment
Five genetic defects have been established as risk factors for venous thrombosis. Three are protein C, protein S, and antithrombin deficiencies, defects in the anticoagulant pathways of blood coagulation. Together they can be found in approximately 15% of families with inherited thrombophilia. Their laboratory diagnosis is hampered by the large genetic heterogeneity of these defects. The other two genetic risk factors, resistance to activated protein C associated with the factor V Leiden mutation and increased prothrombin associated with the prothrombin 20210 A allele, are much more prevalent and together can be found in 63% of the thrombophilia families. Because both defects are caused by a single mutation, DNA analysis is the basis of their laboratory diagnosis.
39
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14
Björn Dahlbäck, Martin Carlsson, Peter J. Svensson · Proceedings of the National Academy of Sciences · 1993 · 2K citations
Ted Koster, FR Rosendaal, Hans de Ronde et al. · The Lancet · 1993 · 1.3K citations
Medicine, Hematology, Hemostasis +14
Deficiency of protein C in congenital thrombotic disease.
John H. Griffin, B. L. Evatt, T S Zimmerman et al. · Journal of Clinical Investigation · 1981 · 1.3K citations · Full text
Medicine, Genetics, Hematology +14